A phase II trial of thymidine and carboplatin for recurrent malignant glioma: A North American brain tumor consortium study Article

Robins, HI, Chang, SM, Prados, MD et al. (2002). A phase II trial of thymidine and carboplatin for recurrent malignant glioma: A North American brain tumor consortium study . NEURO-ONCOLOGY, 4(2), 109-114. 10.1215/S1522851701000515

Open Access

cited authors

  • Robins, HI; Chang, SM; Prados, MD; Yung, WKA; Hess, K; Schiff, D; Greenberg, H; Fink, K; Nicolas, K; Kuhn, JG; Cloughesy, T; Junck, L; Mehta, M

sustainable development goals

authors

publication date

  • April 1, 2002

published in

keywords

  • ALKYLTRANSFERASE
  • CANCER
  • CYTOTOXICITY
  • Clinical Neurology
  • HYPERTHERMIA
  • INFUSIONS
  • INTRAVENOUS CARBOPLATIN
  • INVIVO
  • LEUKEMIA
  • LYMPHOMA
  • Life Sciences & Biomedicine
  • Neurosciences & Neurology
  • Oncology
  • Science & Technology
  • TEMOZOLOMIDE

Digital Object Identifier (DOI)

publisher

  • OXFORD UNIV PRESS INC

start page

  • 109

end page

  • 114

volume

  • 4

issue

  • 2